MTBC Medical Transcription Billing Corp

Alpine ENT Expands Partnership with CareCloud, Implements FrontDesk Assist to Enhance Patient Experience

Alpine ENT Expands Partnership with CareCloud, Implements FrontDesk Assist to Enhance Patient Experience

SOMERSET, N.J., March 26, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO), a leading provider of healthcare technology and AI-powered revenue cycle management (RCM) solutions, today announced the expanded adoption of its services by Alpine Ear, Nose & Throat PC, a premier otolaryngology group based in Colorado. Following a successful RCM engagement, Alpine ENT has now implemented CareCloud FrontDesk Assist—a comprehensive front-office solution designed to streamline operations and enhance patient satisfaction.

“CareCloud has proven to be a true partner in optimizing our practice,” said Mike Heck, CEO of Alpine ENT. “Since deploying FrontDesk Assist, we’ve seen tangible improvements across our front-desk operations. Patient wait times are shorter, appointment scheduling is smoother, and our staff now spends far less time on administrative tasks.”

FrontDesk Assist now supports Alpine ENT with critical front-office functions such as appointment scheduling, referral management, surgery estimates, and prior authorizations. These services complement the existing RCM partnership by boosting operational efficiency and freeing up clinical staff to focus more on patient care.

With 24 providers across three Northern Colorado locations, Alpine ENT delivers a full spectrum of ENT services, including audiology, vestibular therapy, and allergy care. Since implementing FrontDesk Assist, the practice has experienced measurable gains in productivity and patient engagement—underscoring a mutual commitment to innovation, operational excellence, and care quality.

“Alpine ENT’s decision to expand our collaboration speaks to the trust they place in CareCloud’s expertise and solutions,” said Crystal Williams, President of CareCloud. “With FrontDesk Assist, they gain a seamlessly integrated platform that drives both financial and patient-centered outcomes. Our mission is to simplify practice operations so providers can focus on delivering exceptional care.”

This partnership expansion reinforces CareCloud’s dedication to delivering scalable, tech-enabled solutions that help healthcare organizations thrive amid industry transformation. FrontDesk Assist is now available nationwide to healthcare practices of all specialties—including the thousands already using CareCloud’s EHR and RCM platforms.

To learn more about CareCloud FrontDesk Assist, visit .

About CareCloud

CareCloud brings disciplined innovation and generative AI to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health at .

Follow CareCloud on , and .

Disclaimer

This press release is for information purposes only, and does not constitute an offer to sell or solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.

Forward-Looking Statements

This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “shall,” “should,” “could”, “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “seeks,” “estimates,” “predicts,” “possible,” “potential,” “target,” or “continue” or the negative of these terms or other comparable terminology.

Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, the impact of pandemics on our financial performance and business activities, and the expected results from the integration of our acquisitions.

These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry’s) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company’s ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies’ products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange Commission.

The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.

SOURCE CareCloud

Company Contact:

Norman Roth

Interim Chief Financial Officer and Corporate Controller

CareCloud, Inc.

Investor Contact:

Stephen Snyder

Co-Chief Executive Officer

CareCloud, Inc.



EN
26/03/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Medical Transcription Billing Corp

 PRESS RELEASE

CareCloud to Present on AI Innovation at Maxim Group’s 2025 Virtual Te...

CareCloud to Present on AI Innovation at Maxim Group’s 2025 Virtual Tech Conference on June 3, 2025 Somerset, N.J., June 02, 2025 (GLOBE NEWSWIRE) --  (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in AI-driven healthcare technology solutions for medical practices and health systems nationwide, announced today that its Co-Chief Executive Officers have been invited to participate in the “2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow,” presented by Maxim Group LLC. The Healthcare IT Panel, featuring CareCloud, will take place on Tuesday, June 3, 2...

 PRESS RELEASE

CareCloud Announces Results from Annual Shareholders’ Meeting

CareCloud Announces Results from Annual Shareholders’ Meeting Shareholders Re-Elect 3 Board Members, Approve the Compensation for the Company’s Named Executives and Approve the Appointment of Public Accounting Firm SOMERSET, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- (the “Company”) (Nasdaq: CCLD, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that it held its 2025 Annual Shareholders’ Meeting on May 27, 2025, during which shareholders re-elected Anne Busquet, Bill Korn and Lawrence Sharnak for another two-year term. ...

 PRESS RELEASE

CareCloud Named “Top Healthcare IT Pick for 2025” by Maxim Group; AI I...

CareCloud Named “Top Healthcare IT Pick for 2025” by Maxim Group; AI Initiative Recognized as Key Growth Driver SOMERSET, N.J., May 13, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in healthcare technology and generative AI solutions, today announced that Maxim Group, LLC (“Maxim Group”), a leading investment bank, securities and wealth management firm, has selected CareCloud as its “Top Healthcare IT Pick for 2025,” citing the transformative potential of its artificial intelligence strategy, together with its strong financial results and renewe...

 PRESS RELEASE

CareCloud Delivers Growth and Strong Cash Flow in Q1 2025, Advances AI...

CareCloud Delivers Growth and Strong Cash Flow in Q1 2025, Advances AI and Acquisition Strategy SOMERSET, N.J., May 06, 2025 (GLOBE NEWSWIRE) --  (Nasdaq: CCLD, CCLDO), a leader in healthcare technology and generative AI solutions, today announced strong financial results for the three months ended March 31, 2025. CareCloud’s strategic execution, AI-driven innovation, and disciplined financial management have fueled a transformational turnaround, positioning the Company for sustained profitability and long-term growth. Management will discuss these results and the Company’s 2025 growth st...

 PRESS RELEASE

CareCloud Announces Preferred Stock Dividend Payments

CareCloud Announces Preferred Stock Dividend Payments SOMERSET, N.J., May 02, 2025 (GLOBE NEWSWIRE) -- (the “Company”) (Nasdaq: CCLD, CCLDO), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, announced today that its Board of Directors (the “Board”) has declared monthly cash dividends for its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock (“Series A Preferred Stock”) and its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock (“Series B Preferred Stock”) for May and June 2025. The following table...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch